SlideShare una empresa de Scribd logo

MeTA and data disclosure

•Descargar como PPT, PDF•
•
M
MeTApresents

Presentation by Samia Saad, MeTA Baseline Assessments Coordinator, during the MeTA country sharing meeting, London, December 2009.

Salud y medicina
1 de 29
[object Object],[object Object],[object Object],MeTA & Data Disclosure
OUTLINE ,[object Object],[object Object],[object Object]
1. Responsibility for access ,[object Object]
2. Role of transparency ,[object Object]
3. Equity ,[object Object]
4. Evidence-based policy ,[object Object],6 Source WHO 2. Affordable prices ACCESS 1. Rational selection 4. Reliable health and supply systems 3. Sustainable financing
5. Mutual accountability through mutli-stakeholder action ,[object Object],7
Data Disclosure META Disclosure Transparency Improve Access to Medicines
How MeTA assists disclosure process ,[object Object],[object Object],[object Object]
Assisting the data disclosure process - objectives ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],Data Disclosure How does the 'Data Disclosure' fit in with our national MeTA projects?
Key data collected/disclosed in MeTA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Who should disclose what? ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],Data Disclosure Survey
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],KEY POINTS (I) Data Disclosure Survey
[object Object],[object Object],[object Object],[object Object],KEY POINTS (II) Data Disclosure Survey
[object Object],[object Object],[object Object],[object Object],KEY MESSAGE Data Disclosure Survey
[object Object],[object Object],[object Object],Suggested TIMELINES Data Disclosure Survey
MeTA Baseline Assessments
[object Object],[object Object],[object Object],[object Object],Baseline -Introduction
[object Object],[object Object],Baseline Introduction cont.
Objective of Baseline track national progress Long term evaluation of outcomes Level of engagement of different stakeholders country-specific indicators
Suggested Baseline Assessment Components COMPONENT OBJECTIVE TOOL Component 1. Inventory of existing pharmaceutical sector data - that is then made publicly available ,[object Object],[object Object],Component 2. Indication of degree of community access to essential medicines - through healthcare facility and household surveys ,[object Object],[object Object],Component 3. Indication of quality of multi-stakeholder process - includes 360-degree assessment of existing levels of engagement Multi-stakeholder engagement & communication survey
[object Object],Status of Baseline Assessments Component 1. Component 2. Component 3. Jan. 2010 Disclosure survey complete (7 countries) Pharma sector scan (Gh & Phil.) Jor. Kyrg., Peru, Ug., Za. 1st April 2010 Ug. (2008) Gh. & Phil . Jor. (ongoing) Ug, Ph. Kyrg., Jor.,Peru Phil., Za.
Overview MeTA Countries Data Disclosure Surveys
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Disclosure Process in MeTA Countries
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Key Challenges
Samia Saad - International Consultant (Coordinator) Email: samiasaad@gmail.com Wilbert Bannenberg - Technical Director, Int. MeTA Sec. Email: wbannenberg@metasecretariat.org Elodie Brandamir - Operations Director, Int. MeTA Sec. Email: ebrandamir@metasecretariat.org Key Contacts - MeTA Baseline Assessments
Thank You for your attention!

Recomendados

MeTA Baseline Assessments
MeTA Baseline AssessmentsMeTA Baseline Assessments
MeTA Baseline Assessments
SamiaGS
 
What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?
Canadian Cancer Survivor Network
 
Pdmp 4 kreiner small
Pdmp 4 kreiner smallPdmp 4 kreiner small
Pdmp 4 kreiner small
OPUNITE
 
eRX Webinar - State Health Information Exchange Leadership Forum
eRX Webinar - State Health Information Exchange Leadership ForumeRX Webinar - State Health Information Exchange Leadership Forum
eRX Webinar - State Health Information Exchange Leadership Forum
Brian Ahier
 
Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.
Canadian Organization for Rare Disorders
 
Webinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% SolutionWebinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% Solution
Canadian Organization for Rare Disorders
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Canadian Organization for Rare Disorders
 
FHS Nigeria
FHS NigeriaFHS Nigeria
FHS Nigeria
IDS
 

Recomendados

MeTA Baseline Assessments
MeTA Baseline AssessmentsMeTA Baseline Assessments
MeTA Baseline Assessments
SamiaGS
 
What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?
Canadian Cancer Survivor Network
 
Pdmp 4 kreiner small
Pdmp 4 kreiner smallPdmp 4 kreiner small
Pdmp 4 kreiner small
OPUNITE
 
eRX Webinar - State Health Information Exchange Leadership Forum
eRX Webinar - State Health Information Exchange Leadership ForumeRX Webinar - State Health Information Exchange Leadership Forum
eRX Webinar - State Health Information Exchange Leadership Forum
Brian Ahier
 
Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.
Canadian Organization for Rare Disorders
 
Webinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% SolutionWebinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% Solution
Canadian Organization for Rare Disorders
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Canadian Organization for Rare Disorders
 
FHS Nigeria
FHS NigeriaFHS Nigeria
FHS Nigeria
IDS
 
How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...
Canadian Cancer Survivor Network
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
Δρ. Γιώργος K. Κασάπης
 
Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013
Georgi Daskalov
 
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
Foundation for Democratic Advancement
 
ILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes ProjectILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes Project
Mary Fickling
 
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
Forward360 LLC
 
Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.
David Lovelace, CPHIMS, MHSA
 
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Albert Saphier
 
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesMedicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of Medicines
IMS Health US
 
ATMPs.pdf
ATMPs.pdfATMPs.pdf
ATMPs.pdf
CarolinaSuaste
 
Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018
PhRMA
 
Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018
PhRMA
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
OPUNITE
 
Patient in the digital world
Patient in the digital worldPatient in the digital world
Patient in the digital world
PwC Polska
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
OPUNITE
 
Poster, advancements in care coordination mn sim
Poster, advancements in care coordination mn simPoster, advancements in care coordination mn sim
Poster, advancements in care coordination mn sim
soder145
 
How Changes to the PMPRB Could Affect Patients' Access to Drugs
How Changes to the PMPRB Could Affect Patients' Access to DrugsHow Changes to the PMPRB Could Affect Patients' Access to Drugs
How Changes to the PMPRB Could Affect Patients' Access to Drugs
Canadian Cancer Survivor Network
 
Health Canada calls for new tools to control drug prices: what will it mean ...
Health Canada calls for new tools to control drug prices: what will it mean ... Health Canada calls for new tools to control drug prices: what will it mean ...
Health Canada calls for new tools to control drug prices: what will it mean ...
Canadian Cancer Survivor Network
 
LIMITATIONS
LIMITATIONSLIMITATIONS
LIMITATIONS
Brian O. Ogbonna
 
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
SciForce
 
MeTA Assessment Toolbox
MeTA Assessment ToolboxMeTA Assessment Toolbox
MeTA Assessment Toolbox
MeTApresents
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
MeTApresents
 

Más contenido relacionado

La actualidad más candente

How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...
Canadian Cancer Survivor Network
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
Δρ. Γιώργος K. Κασάπης
 
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
Foundation for Democratic Advancement
 
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Albert Saphier
 
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesMedicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of Medicines
IMS Health US
 

La actualidad más candente (20)

How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
 
Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013
 
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
FDA Media Study of the 2012 Alberta Provincial Election (Revised as of April ...
 
ILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes ProjectILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes Project
 
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
 
Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.
 
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1Clinical integration --_tri_state_pho_analysis_(highlighted)-1
Clinical integration --_tri_state_pho_analysis_(highlighted)-1
 
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesMedicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of Medicines
 
ATMPs.pdf
ATMPs.pdfATMPs.pdf
ATMPs.pdf
 
Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018
 
Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018Prescription Medicines - Costs in Context - September 2018
Prescription Medicines - Costs in Context - September 2018
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
 
Patient in the digital world
Patient in the digital worldPatient in the digital world
Patient in the digital world
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
 
Poster, advancements in care coordination mn sim
Poster, advancements in care coordination mn simPoster, advancements in care coordination mn sim
Poster, advancements in care coordination mn sim
 
How Changes to the PMPRB Could Affect Patients' Access to Drugs
How Changes to the PMPRB Could Affect Patients' Access to DrugsHow Changes to the PMPRB Could Affect Patients' Access to Drugs
How Changes to the PMPRB Could Affect Patients' Access to Drugs
 
Health Canada calls for new tools to control drug prices: what will it mean ...
Health Canada calls for new tools to control drug prices: what will it mean ... Health Canada calls for new tools to control drug prices: what will it mean ...
Health Canada calls for new tools to control drug prices: what will it mean ...
 
LIMITATIONS
LIMITATIONSLIMITATIONS
LIMITATIONS
 
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
Development of the Web Service Model for the Evidence-Based Pharmaceutical Ca...
 

Similar a MeTA and data disclosure

D1.2 Review of Policies of Perspectives on Real-World Data
D1.2 Review of Policies of Perspectives on Real-World DataD1.2 Review of Policies of Perspectives on Real-World Data
D1.2 Review of Policies of Perspectives on Real-World Data
Amr Makady
 
HIT Policy Committee Information Exchange Workgroup 9-13-10
HIT Policy Committee Information Exchange Workgroup 9-13-10HIT Policy Committee Information Exchange Workgroup 9-13-10
HIT Policy Committee Information Exchange Workgroup 9-13-10
Brian Ahier
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM Presentation
Daniela Margiotta
 
Patient Identification and Matching Initiative Stakeholder Meeting
Patient Identification and Matching Initiative Stakeholder MeetingPatient Identification and Matching Initiative Stakeholder Meeting
Patient Identification and Matching Initiative Stakeholder Meeting
Brian Ahier
 
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
Kathlene Smith
 
Legal barriers to better use of health data to deliver pharmaceutical innovation
Legal barriers to better use of health data to deliver pharmaceutical innovationLegal barriers to better use of health data to deliver pharmaceutical innovation
Legal barriers to better use of health data to deliver pharmaceutical innovation
Office of Health Economics
 

Similar a MeTA and data disclosure (20)

MeTA Assessment Toolbox
MeTA Assessment ToolboxMeTA Assessment Toolbox
MeTA Assessment Toolbox
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
 
Me Ta Private Sector Meeting 23 June 2009
Me Ta Private Sector Meeting 23 June 2009Me Ta Private Sector Meeting 23 June 2009
Me Ta Private Sector Meeting 23 June 2009
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in Jordan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
Challenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in Ghana
 
MeTA: Overview and lessons learned in pilot countries
MeTA: Overview and lessons learned in pilot countriesMeTA: Overview and lessons learned in pilot countries
MeTA: Overview and lessons learned in pilot countries
 
MeTA: Overview and lessons learned in pilot countries
MeTA: Overview and lessons learned in pilot countriesMeTA: Overview and lessons learned in pilot countries
MeTA: Overview and lessons learned in pilot countries
 
D1.2 Review of Policies of Perspectives on Real-World Data
D1.2 Review of Policies of Perspectives on Real-World DataD1.2 Review of Policies of Perspectives on Real-World Data
D1.2 Review of Policies of Perspectives on Real-World Data
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare IT21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare IT
 
Stakeholder Engagement
Stakeholder EngagementStakeholder Engagement
Stakeholder Engagement
 
FHIR for Life Sciences
FHIR for Life SciencesFHIR for Life Sciences
FHIR for Life Sciences
 
HIT Policy Committee Information Exchange Workgroup 9-13-10
HIT Policy Committee Information Exchange Workgroup 9-13-10HIT Policy Committee Information Exchange Workgroup 9-13-10
HIT Policy Committee Information Exchange Workgroup 9-13-10
 
CSO & media orientation workshop
CSO & media orientation workshopCSO & media orientation workshop
CSO & media orientation workshop
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM Presentation
 
The Next Frontier to Support Health Resource Tracking
The Next Frontier to Support Health Resource TrackingThe Next Frontier to Support Health Resource Tracking
The Next Frontier to Support Health Resource Tracking
 
Patient Identification and Matching Initiative Stakeholder Meeting
Patient Identification and Matching Initiative Stakeholder MeetingPatient Identification and Matching Initiative Stakeholder Meeting
Patient Identification and Matching Initiative Stakeholder Meeting
 
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
HC4110_FinalPaper_NewModelEHR_SmithKR_05062016
 
Legal barriers to better use of health data to deliver pharmaceutical innovation
Legal barriers to better use of health data to deliver pharmaceutical innovationLegal barriers to better use of health data to deliver pharmaceutical innovation
Legal barriers to better use of health data to deliver pharmaceutical innovation
 

Más de MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
MeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
MeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
MeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
MeTApresents
 

Más de MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
MeTA MSP workshop: Follow up activities - World Cafe
MeTA MSP workshop: Follow up activities - World CafeMeTA MSP workshop: Follow up activities - World Cafe
MeTA MSP workshop: Follow up activities - World Cafe
 
Theory of Change
Theory of ChangeTheory of Change
Theory of Change
 

Último

Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
Sheetaleventcompany
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
Sheetaleventcompany
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
Sheetaleventcompany
 
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Jyoti singh
 
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
gragneelam30
 
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Sheetaleventcompany
 
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Namrata Singh
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
jimmihoslasi
 
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
soniya pandit
 
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
Sheetaleventcompany
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
MedicoseAcademics
 
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Oleg Kshivets
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Sheetaleventcompany
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
Sheetaleventcompany
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
Sheetaleventcompany
 

Último (20)

tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacytongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacy
 
Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
Gorgeous Call Girls Dehradun {8854095900} ❤️VVIP ROCKY Call Girls in Dehradun...
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
 
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
 
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
 
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
 
Intramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptxIntramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptx
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
 
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
 
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
 
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
Jaipur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Jaipur No💰...
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
 

MeTA and data disclosure

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. Data Disclosure META Disclosure Transparency Improve Access to Medicines
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 20.
  • 21.
  • 22. Objective of Baseline track national progress Long term evaluation of outcomes Level of engagement of different stakeholders country-specific indicators
  • 23.
  • 24.
  • 25. Overview MeTA Countries Data Disclosure Surveys
  • 26.
  • 27.
  • 28. Samia Saad - International Consultant (Coordinator) Email: samiasaad@gmail.com Wilbert Bannenberg - Technical Director, Int. MeTA Sec. Email: wbannenberg@metasecretariat.org Elodie Brandamir - Operations Director, Int. MeTA Sec. Email: ebrandamir@metasecretariat.org Key Contacts - MeTA Baseline Assessments
  • 29. Thank You for your attention!